NYXOAH news, videos and press releases
For more news please use our advanced search feature.
NYXOAH - More news...
NYXOAH - More news...
- EQS-News: Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
- Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
- EQS-News: Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
- Publication relating to transparency notifications
- EQS-News: Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
- Information on the total number of voting rights and shares
- Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
- Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
- Publication relating to transparency notifications
- EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results
- Nyxoah Appoints John Landry as Chief Financial Officer
- Publication relating to transparency notifications
- Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
- Publication relating to transparency notifications
- EQS-News: Nyxoah Raises $27 Million through its At-the-Market Offering
- Nyxoah Raises $27 Million through its At-the-Market Offering
- EQS-News: DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
- Information on the total number of voting rights and shares
- EQS-News: Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
- Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
- EQS-News: Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
- EQS-News: Nyxoah Appoints Scott Holstine as Chief Commercial Officer
- EQS-News: Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank
- Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
- Information on the total number of voting rights and shares
- Information on the total number of voting rights and shares
- Publication relating to transparency notifications
- Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
- Information on the Total Number of Voting Rights and Shares
- Nyxoah Announces Pricing of Offering
